Search Within

Layal Al Mahmasani

Formats
  1. Meeting Abstract (3)
  2. Editorial (1)
  3. Journal Article (1)
  4. Review (1)
Groups
  1. Department of Medicine (6)
  2. Gastrointestinal Oncology Service (6)
  3. Solid Tumor Oncology Division (6)
  4. Biostatistics Service (3)
  5. Center for Pancreatic Cancer Research (3)
  6. Department of Pathology and Laboratory Medicine (3)

More Groups

People
  1. Ghassan Abou-Alfa (6)
  2. Eileen O'Reilly (3)
  3. James Harding (3)
  4. Marinela Capanu (3)
  5. Amin Yaqubie (2)
  6. Amitabh Srivastava (2)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
Publications
  1. Journal of Clinical Oncology (3)
  2. American Heart Journal Plus (1)
  3. Hematology/Oncology Clinics of North America (1)
  4. Journal of Gastrointestinal Oncology (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Elsevier Inc. (2)
  3. Pioneer Bioscience Publishing Company (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Obesity and biliary tract cancers: Changing epidemiology
    Meeting Abstract

    Al Mahmasani, L.; Chou, J. F.; Capanu, M.; Srivastava, A.; Sigel, C. S.; Alsuwailem, R.; Berger, M. F.; Khalil, D. N.; Harding, J. J.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Balancing anticancer therapy efficacy and safety in advanced hepatocellular carcinoma: A case report
    Journal Article

    Mourad, M.; Al Mahmasani, L.; Abbas, N.; Sainamthip, P.; Freile, B.; Zayed, A.; Alsuwailem, R.; Khatib, O.; Sinno, S.; Sabatin, F.; more...
    Journal of Gastrointestinal Oncology (2024)

    Fulltext@MSK | Save
  • Fibrolamellar carcinoma registry: Opportunities and challenges
    Meeting Abstract

    Al Mahmasani, L.; Capanu, M.; Losert, K.; Lowery, M. A.; Hennessy, M.; Ray, M.; Chambers, S.; Yaqubie, A.; Zarski, A.; El Dika, I. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Body mass index (BMI) as a prelude to hepatocellular carcinoma (HCC) and metabolic dysfunction-associated steatohepatitis (MASH) risk factors in patients with no identified risk factor for developing hepatocellular carcinoma (HCC)
    Meeting Abstract

    Al Mahmasani, L.; Capanu, M.; Srivastava, A.; Chou, J. F.; Shia, J.; El Dika, I. H.; Yaqubie, A.; Harding, J. J.; O'Reilly, E. M.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Cardiovascular implications of anti-angiogenic therapeutic agents in cancer patients
    Editorial

    Al Mahmasani, L.; Abou-Alfa, G. K.
    American Heart Journal Plus (2024)

    Fulltext@MSK | Save
  • Immunotherapy: A sharp curve turn at the corner of targeted therapy in the treatment of biliary tract cancers
    Review

    Al Mahmasani, L.; Harding, J. J.; Abou-Alfa, G.
    Hematology/Oncology Clinics of North America (2024)

    Fulltext@MSK | Save